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Mutations in the Hinge of a Dynamic Loop Broadly Influence Functional
Properties of Fructose-1,6-bisphosphatase
Abstract
Loop 52–72 of porcine fructose-1,6-bisphosphatase may play a central role in the mechanism of catalysis and
allosteric inhibition by AMP. The loop pivots between different conformational states about a hinge located at
residues 50 and 51. The insertion of proline separately at positions 50 and 51 reduces k cat by up to 3-fold,
with no effect on the K m for fructose 1,6-bisphosphate. TheK a for Mg2+ in the Lys50→ Pro mutant increases
∼15-fold, whereas that for the Ala51 → Pro mutant is unchanged. Although these mutants retain wild-type
binding affinity for AMP and the fluorescent AMP analog 2′(3′)-O-(trinitrophenyl)adenosine 5′-
monophosphate, the K i for AMP increases 8000- and 280-fold in the position 50 and 51 mutants,
respectively. In fact, the mutation Lys50 → Pro changes the mechanism of AMP inhibition with respect to
Mg2+ from competitive to noncompetitive and abolishes K+ activation. The K i for fructose 2,6-bisphosphate
increases ∼20- and 30-fold in the Lys50 → Pro and Ala51 → Pro mutants, respectively. Fluorescence from a
tryptophan introduced by the mutation of Tyr57suggests an altered conformational state for Loop 52–72 due
to the proline at position 50. Evidently, the Pro50 mutant binds AMP with high affinity at the allosteric site,
but the mechanism of allosteric regulation of catalysis has been disabled.
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Loop 52–72 of porcine fructose-1,6-bisphosphatase
may play a central role in the mechanism of catalysis
and allosteric inhibition by AMP. The loop pivots be-
tween different conformational states about a hinge lo-
cated at residues 50 and 51. The insertion of proline
separately at positions 50 and 51 reduces kcat by up to
3-fold, with no effect on the Km for fructose 1,6-bisphos-
phate. The Ka for Mg
21 in the Lys50 3 Pro mutant in-
creases ;15-fold, whereas that for the Ala51 3 Pro mu-
tant is unchanged. Although these mutants retain wild-
type binding affinity for AMP and the fluorescent AMP
analog 2*(3*)-O-(trinitrophenyl)adenosine 5*-monophos-
phate, the Ki for AMP increases 8000- and 280-fold in the
position 50 and 51 mutants, respectively. In fact, the
mutation Lys50 3 Pro changes the mechanism of AMP
inhibition with respect to Mg21 from competitive to non-
competitive and abolishes K1 activation. The Ki for fruc-
tose 2,6-bisphosphate increases ;20- and 30-fold in the
Lys503 Pro and Ala513 Pro mutants, respectively. Flu-
orescence from a tryptophan introduced by the muta-
tion of Tyr57 suggests an altered conformational state
for Loop 52–72 due to the proline at position 50. Evi-
dently, the Pro50 mutant binds AMP with high affinity at
the allosteric site, but the mechanism of allosteric reg-
ulation of catalysis has been disabled.
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-
phosphohydrase, EC 3.1.3.11; FBPase)1 catalyzes the hydroly-
sis of fructose 1,6-bisphosphate (Fru-1,6-P2) to Fru-6-P and Pi
(for a review, see Refs. 1–3). FBPase is a tetramer of identical
subunits (Mr 5 37,000). Each subunit has binding sites for
Fru-1,6-P2, Fru-2,6-P2, and metal ions (which, taken together,
define the active site) and a distinct AMP-binding site (4–6).
The two binding loci within the same subunit are 28 Å apart,
lying for the most part in separate folding domains (called the
AMP and Fru-1,6-P2 domains). The four subunits of the tet-
ramer occupy the corners of a rectangle, labeled clockwise C1
through C4, starting with the upper left-hand corner (7). FB-
Pase exists in at least two conformational states, called R and
T, which differ by a 17o rotation of the C1-C2 subunit pair with
respect to the C3-C4 subunit pair about one of three intersect-
ing 2-fold axes of the tetramer (7, 8).
Loop 52–72 could play an important role in the allosteric
mechanism of AMP inhibition, existing in at least two confor-
mational states (9, 10). In the absence of AMP, the loop inter-
acts with the active site (engaged loop conformation), position-
ing the side chain of an essential catalytic residue, Asp74 (9,
11). The binding of AMP to its allosteric pocket putatively
displaces the loop from the active site and stabilizes the disen-
gaged loop conformation (9, 10). Subunits with disengaged
loops evidently have reduced affinity for essential metal ions
and, as a consequence, may be impaired with respect to catal-
ysis. Mutations of conserved residues in Loop 52–72 have sig-
nificant effects on catalysis and allosteric inhibition of catalysis
by AMP (11).
The metabolic flux through FBPase is sensitive to prevailing
levels of AMP and Fru-2,6-P2. AMP inhibits FBPase allosteri-
cally with a Hill coefficient of 2 (12, 13), whereas Fru-2,6-P2
inhibits FBPase by direct ligation of the active site with a Hill
coefficient of unity (1–3). Inhibition of FBPase by AMP is non-
linear and noncompetitive with respect to Fru-1,6-P2, but non-
linear and competitive with respect to Mg21 (6, 14). In contrast,
inhibition of FBPase by Fru-2,6-P2 is linear and competitive
with respect to Fru-1,6-P2 and noncompetitive with respect to
Mg21. Due to the equilibrium reaction catalyzed by adenylate
kinase, concentrations of AMP in vivo are nearly constant
under normal physiological conditions, whereas the concentra-
tion of Fru-2,6-P2 varies in response to extracellular regulators
such as glucagon and epinephrine. Hence, Fru-2,6-P2 is the
probable dynamic regulator of FBPase in vivo, but AMP still
plays a significant role. Fru-2,6-P2 lowers the apparent inhibi-
tion constant for AMP at least 10-fold (15) by decreasing the koff
of AMP (16). Levels of AMP association with the allosteric sites
of FBPase will then necessarily change in response to Fru-
2,6-P2 levels, even if the concentration of AMP in vivo is con-
stant. AMP/Fru-2,6-P2 synergism may arise from the ability of
each ligand to stabilize a common thermodynamic state of
FBPase (disengaged Loop 52–72) through different mecha-
nisms (9).
For Loop 52–72 to move between its various states, signifi-
cant conformational change must occur in hinge elements at
residues 50 and 51 and residues 71 and 72. The combined
mutation of lysines 71 and 72 to methionine dramatically in-
creases the Ki for AMP, presumably due to the stabilization of
the R-state over the T-state conformer of FBPase (11). If the
loop-mediated mechanism of AMP inhibition is valid, muta-
tions at the second hinge element must qualitatively cause a
similar increase in the Ki for AMP, yet mutations of Lys
50 to
methionine (17) and glutamine and alanine (18) cause virtually
no change in the Ki for AMP. What is clear from crystal struc-
tures, however, is a large difference in main chain angles (f, w)
at position 50 in the R- and T-states of FBPase (7, 9, 10). Here
we explore the consequence of mutations Lys50 3 Pro and
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Ala51 3 Pro, which directly influence the backbone conforma-
tion of residues 50 and 51. The mutations have little effect on
the binding affinity of a fluorescent analog of AMP, but in-
crease the kinetic Ki value for that analog by several orders of
magnitude. The kinetic Km value for Fru-1,6-P2 is unchanged
by the mutations, but the Ka for Mg
21 rises 15-fold in the case
of the Pro50 mutant and is 40-fold less active under standard
conditions of assay. The data suggest that Loop 52–72 is an
essential element in the allosteric mechanism of FBPase.
EXPERIMENTAL PROCEDURES
Materials—Fru-1,6-P2, Fru-2,6-P2, NADP
1, AMP, ampicillin, and
isopropyl-b-D-thiogalactopyranoside were purchased from Sigma. DNA-
modifying and restriction enzymes, T4 polynucleotide kinase, and li-
gase were from Promega. Glucose-6-phosphate dehydrogenase and
phosphoglucose isomerase came from Roche Molecular Biochemicals.
Tryptone, yeast extract, and agar were from Difco. Other chemicals
were of reagent grade or equivalent. Escherichia coli strains BMH71-18
mutS and XL1-Blue came from CLONTECH and Stratagene, respec-
tively. FBPase-deficient strain DF657 came from the Genetic Stock
Center at Yale University.
Mutagenesis of Wild-type FBPase—Mutations were accomplished by
specific base changes in double-stranded plasmid using the Transform-
erTM site-directed mutagenesis kit (CLONTECH). The mutagenic prim-
ers for the Lys50 3 Pro, Ala51 3 Pro, and Tyr57 3 Trp mutants were
59-GTCCGCCCGGCGGGCATC-39, 59-CCGCAAGCCGGGCATCGC-39,
and 59-CGCACCTCTGGGGAATTG39, respectively (codons for muta-
tion are in boldface and underlined). The selection primer 59-CAGC-
CTCGCCTCGAGAACGCCA-39 (the digestion site is in boldface and
underlined) changed an original NruI site on the plasmid into a XhoI
site. The mutation and integrity of the gene were confirmed by sequenc-
ing the entire gene. The Iowa State University sequencing facility
provided DNA sequences using the fluorescent dye dideoxy terminator
method.
Expression and Purification of Wild-type and Mutant FBPases—
Protein expression and purification were performed as described previ-
ously (11), but with minor alterations. After cell breakage, FBPase was
enriched and concentrated by 70% ammonium sulfate fractionation.
The precipitate was taken up in 20 mM Tris (pH 7.5) and desalted on a
Sephadex G-100 column using 20 mM Tris (pH 7.5). The active fractions
were loaded directly onto a Cibacron blue column and eluted with a
0.5–1 M NaCl gradient. FBPase eluted at ;800 mM NaCl. The eluent
was dialyzed against 20 mM Tris-HCl (pH 8.3), loaded onto a DEAE-
Sephadex column, and then developed with a 0–300 mM NaCl gradient.
FBPase eluted at a salt concentration of 150 mM, and its purity was
confirmed by SDS-polyacrylamide gel electrophoresis (19). Protein con-
centration was determined using the Bradford assay (20) with bovine
serum albumin as a standard.
Circular Dichroism Spectroscopy—CD studies on wild-type and mu-
tant FBPases were done at room temperature on a Jasco J710 CD
spectrometer in a 1-cm cell using a protein concentration of 0.35 mg/ml.
Spectra were collected from 200 to 260 nm in increments of 1.3 nm.
Each spectrum was blank-corrected and smoothed using the software
package provided with the instrument.
Kinetic Experiments—Assays for the determination of specific activ-
ity, kcat, and activity ratios at pH 7.5 and 9.5 employed the coupling
enzymes phosphoglucose isomerase and glucose-6-phosphate dehydro-
genase (1). The reduction of NADP1 to NADPH was monitored directly
at 340 nm. All other assays employed the same coupling enzymes, but
monitored NADPH evolution by its fluorescence emission at 470 nm
(excitation wavelength of 340 nm). Initial rate data were analyzed using
either programs written in the MINITAB language using an a value of
2.0 (14) or ENZFITTER (21). The kinetic data were fit to a variety of
models. Only models and parameters for the best fits are reported
below.
Steady-state Fluorescence Measurements—Fluorescence data were
collected using an SLM 8100C fluorometer (Spectronic Instruments).
The single tryptophan in the Trp57 mutant was excited selectively using
radiation of 295-nm wavelength. Fluorescence emission spectra were
recorded in steps of 1 nm from 310 to 400 nm using a slit width of 2 mm
for both excitation and emission. Each spectrum was an average of five
scans. Fluorescence from TNP-AMP employed excitation and emission
wavelengths of 400 and 535 nm, respectively. Conditions under which
specific spectra were recorded are provided below and in the tables and
figure legends. Each point is the average of 15 1-s acquisitions. Enzyme
concentrations ranged from 0.3 to 0.5 mM. All spectra were corrected for
dilution and inner filter effects (absorbance of light by AMP and TNP-
AMP) using Equation 1 (22),
Fc 5 ~F 2 B!~Vi/V0!10~Aex1Aem)/2 (Eq. 1)
where Fc is the corrected fluorescence, F is the fluorescence intensity
experimentally measured, B is the background, Vi is the volume of the
sample for a specific titration point, V0 is the initial volume of the
sample, Aex is the absorbance measured at the wavelength of excitation
(295 nm for AMP and 410 nm for TNP-AMP), and Aem is the absorbance
measured at the wavelength of emission (535 nm for TNP-AMP). As a
control, ligands by themselves caused no change in fluorescence emis-
sion from a solution of tryptophan (100 mM).
TNP-AMP titration data were analyzed by nonlinear least-squares
fits using Equation 2,
DF
Fo
5
~DFmax/F0! z Ln
Kd 1 Ln
(Eq. 2)
where DF is the change in fluorescence caused by the addition of ligand
(L), F0 is the fluorescence in the absence of ligand, DFmax is the theo-
retical maximum change in fluorescence at saturating ligand concen-
tration, Kd is the dissociation constant, and n is the Hill coefficient.
Structural Modeling of FBPase Mutants—The starting model for the
engaged conformation of Loop 52–72 is the crystal structure of the
Zn21zproduct complex of FBPase (PDB accession code 1CNQ), in which
the tetramer assumes the R-state conformation (9). The starting model
for the disengaged conformation of Loop 52–72 is a Zn21zproductzAMP
complex of FBPase, in which the tetramer has the T-state conformation
(10). The latter structure is similar to other T-state structures of FB-
Pase (7, 23), differing primarily in the ligands present at the active site.
Proline residues were placed individually at positions 50 and 51 using
the software XTALVIEW and a Silicon Graphics workstation. The ini-
tial models were passed through three protocols: 1) 100 cycles of con-
jugate gradient minimization; 2) 100 cycles of conjugate gradient min-
imization, followed by simulated annealing (starting temperature, 500
K; final temperature, 300 K) (24) and then another 100 cycles of con-
jugate gradient minimization; and 3) the same procedure as Protocol 2,
but using a starting temperature of 1000 K. During simulated anneal-
ing and energy minimization, the Ca atoms (except for residues 50–72)
were restrained to their initial crystallographic positions by a harmonic
pseudo-potential with a force constant of 50 kcal/mol. The justification
for restraining all Ca atoms outside of the loop is the 10-year history of
FBPase crystal structures, which collectively reveal only small changes
in the protein conformation outside of Loop 52–72.
RESULTS
Modeling of FBPase Mutants—A structural overview of the
region of interest is provided in Fig. 1. The main chain f angle
of Lys50 differs significantly in the T- and R-states, neither
value being compatible with that of proline, where f must be
close to 260°. Insertion of proline then results in an initial
model with poor stereochemistry at position 50. Energy mini-
mization alone and energy minimization with simulated an-
nealing at a starting temperature of 500 K (Protocols 1 and 2 in
“Experimental Procedures”) leave the f angle of Pro50 some 30°
away from its preferred value in both the T- and R-states.
Further improvement in the stereochemistry of Pro50 requires
a starting temperature of 1000 K in simulated annealing (Pro-
tocol 3), the consequence of which is a significant drift of the
Loop 52–72 away from either its T- or R-state conformation.
Evidently, proline at position 50 is incompatible with the
T-state disengaged and R-state engaged loop conformations.
Proline at position 51, on the other hand, is less disruptive.
The f angle of residue 51 is near 260° in both the R- and
T-states of FBPase. Backbone amide 51 hydrogen bonds with
backbone carbonyls 47 and 48 in the R-state and with backbone
carbonyl 46 in the T-state. Proline substitution at position 51
clearly disrupts the hydrogen bonds in both the R- and
T-states. Moreover, the Cd atom of proline makes close contacts
of 1.9 and 1.8 Å with backbone carbonyls 48 (R-state) and 46
(T-state), respectively. Either energy minimization alone or
energy minimization with simulated annealing (initial temper-
ature, 500 K) relaxes the contact in the R-state (the loop re-
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mains engaged with the active site) by a 90° rotation of the
plane of the polypeptide linkage between residues 47 and 48.
The close contact of the T-state remains, however, at 2.4 and
2.8 Å after modeling Protocols 1 and 2, respectively. Contacts
from within the subunit and from the neighboring subunit
constrain the T-state conformation of residues 52–57 (Fig. 1).
Furthermore, as backbone carbonyl 46 is an integral part of
helix H2, it cannot relieve its close contact with Pro51 by a
rotation of its polypeptide linkage. Hence, proline at position 51
probably increases the internal energy of the T-state, destabi-
lizing it relative to the R-state of FBPase.
Expression and Purification of Wild-type and Mutant FB-
Pases—Mutant and wild-type FBPases behaved identically
throughout purification, including gel exclusion chromatogra-
phy. The wild-type and mutant enzymes were at least 95% pure
with no evidence for proteolysis on the basis of SDS-polyacryl-
amide gel electrophoresis.
Secondary Structure Analysis—The CD spectra of wild-type
FBPase in the T- and R-states diverge minimally, but repro-
ducibly in the vicinity of 210 nm (17). The CD spectra of the
Ala513 Pro, Lys503 Pro/Tyr573 Trp, and wild-type FBPases
superimpose in the presence of Pi (5 mM), Fru-6-P (5 mM), and
saturating Mg21 (5 mM for the wild-type and Ala51 3 Pro
enzymes and 35 mM for Lys503 Pro/Tyr573 Trp). The addition
of AMP (200 mM) to the wild-type enzyme produced small
changes in the CD spectrum near 210 nm, as noted above, but
caused no change in the CD spectra of the Lys503 Pro/Tyr573
Trp and Ala51 3 Pro enzymes. (Concentrations of AMP in
excess of 200 mM degraded CD spectra due to the elevated
absorbance of radiation.) The CD spectra of the Lys50 3 Pro
mutant also differ from the corresponding wild-type spectra
(Fig. 2). The CD spectrum of the Lys50 3 Pro mutant did not
change in the presence of Pi (5 mM), Fru-6-P (5 mM), and
saturating Mg21 (50 mM) in the presence or absence of AMP
(200 mM).
Catalytic Rates, Michaelis Constants for Mg21 and Fru-1,6-
P2, and K
1 Activation—Initial rate kinetics employ maximal
substrate concentrations, sufficient to saturate the active site,
but low enough to avoid substrate inhibition. The ratios of
catalytic rate constants at pH 7.5 and 9.6 are comparable for
wild-type and Ala51 3 Pro FBPases (Table I), both consistent
with reported activity ratios for an FBPase free of proteolysis.
The activity ratios for the Lys50 3 Pro and Lys50 3 Pro/Tyr57
3 Trp mutants are low, however; but as discussed below, the
low value does not stem from limited proteolysis of that
mutant.
FIG. 1. Wild-type FBPase in the T- and R-states. The upper panels show only the C3-C4 subunit pair from the R-state (left panel) and T-state
(right panel) tetramers. Loop 52–72 from subunit C4 is represented by a thick black line. The regions within the dashed boxes are enlarged in the
lower panels, showing the relative positions of Lys50, Ala51, and Tyr57. This figure was prepared with MOLSCRIPT (32) and RASTER3D (33).
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All enzymes have comparable Km values for Fru-1,6-P2 (Ta-
ble I); but beyond this, the quantitative similarities end. Under
standard conditions of assay for the wild-type enzyme (5 mM
Mg21 and 20 mM Fru-1,6-P2, pH 7.5), the mutation of Lys
50 to
proline resulted in a 40-fold loss of specific activity. However,
the decline in specific activity was due primarily to a 15-fold
increase in the Ka for Mg
21 for the Pro50 mutant. The kcat value
for the Pro50 mutant (saturated with Mg21) is one-third of that
for the wild-type enzyme. The Hill coefficients for Mg21 for the
Ala513 Pro, Lys503 Pro/Tyr573 Trp, and wild-type enzymes
are similar, but are reduced significantly in the Lys50 3 Pro
mutant. Potassium ion activation is retained in the Ala51 3
Pro and Lys50 3 Pro/Tyr57 3 Trp mutants at levels compara-
ble to that of the wild-type enzyme, but is abolished altogether
in the Pro50 mutant.
Kinetics of AMP Inhibition—Concentrations of AMP needed
for 50% inhibition increased 280-, 8000-, and 400-fold relative
to that of the wild-type enzyme for the Ala51 3 Pro, Lys50 3
Pro, and Lys50 3 Pro/Tyr57 3 Trp mutants, respectively (Fig.
3 and Table I). Additionally, the Lys50 3 Pro/Tyr57 3 Trp
double mutant displays biphasic behavior toward AMP. The
data of Fig. 3 for the wild-type, Ala51 3 Pro, and Lys50 3 Pro
enzymes were fit to Equation 3,
v 5
V0
S1 1 S IIC50D
2D (Eq. 3)
where v is the observed velocity at a specific concentration of
AMP, V0 is the fitted velocity in the absence of AMP, I is the
concentration of AMP, and IC50 is the concentration of AMP
that causes 50% inhibition. The exponent of 2 represents the
Hill coefficient for AMP cooperativity, determined independ-
ently as described below. The data of Fig. 3 for Lys50 3 Pro/
Tyr57 3 Trp FBPase were fit to Equation 4,
v 5
V0
S1 1 S IIC50-highD
2
1 S IIC50-lowD
nD (Eq. 4)
where v, V0, and I are as defined above for Equation 3 and
IC50-high and IC50-low represent concentrations of AMP that
cause 50% relative inhibition due to the ligation of high and low
affinity sites, respectively. Ligation of the high affinity sites, as
shown below, is cooperative with a Hill coefficient of 2, whereas
the cooperativity with respect to the ligation of low affinity
sites is an adjustable parameter (n) in Equation 4. The fitted
value for n is 1.4.
AMP inhibition of wild-type FBPase is nonlinear and non-
competitive with respect to Fru-1,6-P2 and nonlinear and com-
petitive with respect to Mg21. The Ala513 Pro mutant retains
the nonlinear, competitive relationship between AMP and
Mg21 (goodness-of-fit, 5.5%) (Fig. 4), consistent with Equation
5,
1
v
5
1
Vm
S1 1 KaA2S1 1 I
n
Ki
DD (Eq. 5)
where v, Vm, A, I, Ka, Ki, and n represent initial velocity,
maximal velocity, Mg21 concentration, AMP concentration, the
Michaelis constant for Mg21, the dissociation constant for AMP
from the enzymezAMP complex, and the Hill coefficient for
AMP, respectively. The binding of AMP is cooperative at n 5 2,
whereas cooperativity is absent when n 5 1. Data from the
wild-type and Ala51 3 Pro enzymes are consistent with n 5 2
(AMP cooperativity). When assayed at low AMP concentra-
tions, Lys50 3 Pro/Tyr57 3 Trp retains the competitive mech-
FIG. 2. CD spectra for wild-type and Lys503 Pro FBPases. Thin
solid line, R-state wild-type enzyme with reaction products and Mg21;
dotted line, T-state wild-type enzyme with reaction products, Mg21, and
AMP; thick solid line, Lys50 3 Pro mutant under either R- or T-state
conditions. mdeg, millidegrees.
FIG. 3. AMP inhibition of wild-type and mutant FBPases. AMP
titrations were of wild-type ( l ), Ala513 Pro (l), Lys503 Pro/Tyr573
Trp (f), and Lys503 Pro () FBPases in saturating Fru-1,6-P2 (20 mM)
and a Mg21 concentration equal to the Ka for Mg
21 of each enzyme. See
“Results” for details regarding the fitted curves.
TABLE I
Kinetic parameters for wild-type and mutant forms of fructose-1,6-bisphosphatase
7.5/9.5
ratio
Specific
activitya kcat
b Km for Fru-1,6-P2 Ka for Mg
21 Hill for Mg21 Ki for Fru-2,6-P2 IC50 for AMP
c K1activationd
units/mg/s s21 mM mM2 mM mM %
Wild-type 3.3 35 6 2 22 6 1 1.75 6 0.09 0.67 6 0.04 1.9 6 0.1 0.123 6 0.005 1.61 6 0.05 16.8 6 0.3
Lys50 3 Pro 0.93 0.85 6 0.06 6.7 6 0.3 2.1 6 0.2 10.7 6 0.8 1.45 6 0.08 2.3 6 0.2 13400 6 20 24.32 6 0.04
Ala51 3 Pro 3.2 20 6 1 12.4 6 0.7 2.5 6 0.2 0.8 6 0.1 2.1 6 0.2 3.4 6 0.2 460 6 7 15.9 6 0.1
Tyr57 3 Trpe 3.3 38.6 6 0.1 24.0 6 0.1 3.39 6 0.09 0.53 6 0.06 1.9 6 0.1 0.84 6 0.05 8.5 6 0.4 16.6 6 0.4
Lys50 3 Pro/
Tyr57 3 Trp 1.9 8.7 6 0.8 9.2 6 0.5 1.3 6 0.1 3.1 6 0.2 1.80 6 0.07 0.37 6 0.03 650 6 40f 14.6 6 0.1
a Specific activity was determined at 5 mM Mg21 and 20 mM Fru-1,6-P2.
b kcat is defined as Vmax/ET, where ET is the total enzyme concentration.
c The Hill coefficient for AMP ligation of high affinity sites is 2. See “Results” for details.
d K1 activation is the percent increase in Vmax using 150 mM KCl versus 0 mM KCl at saturating Mg
21 and Fru-1,6-P2.
e Data are from Ref. 25.
f The reported value is for the high affinity site (IC50-high). IC50-low is 28 6 6 mM with a Hill coefficient of 1.4. See “Results” for details.
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anism with n 5 2. In contrast, AMP inhibition of the Lys50 3
Pro mutant fits best to a mechanism of noncompetitive inhibi-
tion with respect to Mg21 (goodness-of-fit, 3.1%) (Fig. 4), rep-
resented by Equation 6,
1
v
5
1
Vm
S1 1 1nKii 1 KaAS1 1 I
n
Ki
DD (Eq. 6)
where the terms of Equation 6 are defined as for Equation 5
and Kii represents the dissociation constant for AMP from the
enzymezMg21zAMP complex. The data are consistent with n 5
2, reflecting AMP cooperativity.
In wild-type, Ala51 3 Pro, and Lys50 3 Pro/Tyr57 3 Trp
FBPases, the mechanism of AMP inhibition with respect to
Fru-1,6-P2 is nonlinear and noncompetitive (Equation 7),
1
v
5
1
Vm
S1 1 InKii 1 KbBS1 1 I
n
Ki
DD (Eq. 7)
where v, Vm, I, and n are as defined above, Ki and Kii represent
the dissociation constants for AMP from the enzymezAMP and
the enzymezFru-1,6-P2zAMP complexes, respectively, B is the
concentration of Fru-1,6-P2, and Kb is the Michaelis constant
for Fru-1,6-P2. The high value for IC50 associated with AMP
inhibition of the Lys50 3 Pro mutant (Table I) precludes the
determination of a kinetic mechanism.
Kinetics of Fru-2,6-P2 Inhibition—Fru-2,6-P2 is a competi-
tive inhibitor with respect to Fru-1,6-P2 for the position 50 and
51 mutant FBPases. The data best fit to Equation 8 (goodness-
of-fit, 4.0%),
1
v
5
1
Vm
S1 1 KbBS1 1 IKiDD (Eq. 8)
where v, Vm, I, B, Ki, and Kb are as defined above. The kinetic
mechanism of Fru-2,6-P2 inhibition is the same for mutant and
wild-type FBPases, but the Ki for Fru-2,6-P2 is ;20-, 30-, and
3-fold higher in the Lys50 3 Pro, Ala51 3 Pro, and Lys50 3
Pro/Tyr57 3 Trp mutants, respectively, relative to the wild-
type enzyme (Table I).
Fru-2,6-P2 and AMP Synergism—AMP and Fru-2,6-P2 syn-
ergistically inhibited wild-type and mutant FBPases (Fig. 5).
For all enzymes, the Hill coefficient for AMP is 2. At high
concentrations of Fru-2,6-P2, the saturation curve for Fru-
1,6-P2 changes from hyperbolic to sigmoidal for mutant and
wild-type enzymes.
Steady-state Fluorescence Measurements—TNP-AMP inhib-
ited the wild-type enzyme competitively with respect to Mg21
and inhibited FBPase synergistically with Fru-2,6-P2. Fluores-
cence emission from TNP-AMP increased significantly in the
presence of FBPase. In addition, AMP reduced the fluorescence
from bound TNP-AMP, presumably through competition for
the allosteric effector site (data not shown). TNP-AMP bound to
wild-type, Lys50 3 Pro, and Ala51 3 Pro FBPases with high
FIG. 5. AMP/Fru-2,6-P2 synergism for wild-type (A) and Ala
513
Pro (B) FBPases. The concentrations of Fru-2,6-P2 were 0 (l) and
approximately one-fourth of the Ki for Fru-2,6-P2 (0.03 mM for wild-type
FBPase and 0.86 mM for the Ala513 Pro mutant) (). Assays had Mg21
concentrations equal to the Ka for Mg
21 of each enzyme and saturating
levels of Fru-1,6-P2 (20 mM).
TABLE II
Inhibition and binding constants for TNP-AMP for wild-type and
mutant forms of fructose-1,6-bisphosphatase
IC50 for TNP-AMP Kd for TNP-AMP
mM mM
Wild-type 7.4 6 0.7 13.1 6 0.6
Lys50 3 Pro NDa 14 6 4
Ala51 3 Pro ND 37 6 2
a Not determined due to weak inhibition by TNP-AMP.
FIG. 4. Kinetic mechanism of inhibition of Ala51 3 Pro and
Lys503Pro FBPases. A, AMP competes with Mg21 in the Ala513 Pro
mutant. Concentrations of AMP were 0 (l), 100 mM (f), and 225 mM ().
B, AMP inhibition is noncompetitive with respect to Mg21 in the Lys50
3 Pro mutant. Concentrations of AMP were 0 (l), 10 mM (f), 15 mM
(), and 20 mM (l ). All assays were performed at saturating concen-
trations of Fru-1,6-P2 (20 mM) and at 150 mM KCl. The lines are based
upon Equation 5 for A and Equation 6 for B using the parameters of
Table I. A.U., arbitrary units.
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affinity, comparable to AMP. On the basis of fluorescence ti-
tration data (Table II), however, the Hill coefficient for TNP-
AMP is near unity in all cases.
FBPase has no tryptophan, so the mutation of any single
residue to tryptophan introduces a unique fluorophore. Fluo-
rescence emission from tryptophan at position 57 is sensitive to
the conformational state of Loop 52–72. The indole of Trp57 is
exposed to solvent in the T-state disengaged loop conformation,
whereas it resides in a hydrophobic pocket in the R-state en-
gaged loop conformation. The Tyr57 3 Trp mutant has been
thoroughly studied by x-ray crystallography and initial velocity
kinetics (25). Fluorescence emission spectra from the Pro50/
Trp57 double mutant differ significantly from those of the Trp57
single mutant (Fig. 6). Fluorescence emission from the single
Trp57 mutant is maximum in the presence of products/metals,
conditions that promote the R-state engaged loop conformation
(9, 10). The addition of AMP reduced fluorescence emission to a
level comparable to that observed from the Trp57 mutant in the
absence of products and metals (apo form of FBPase). In con-
trast, the apo form of the Pro50/Trp57 double mutant has the
highest fluorescence emission. The addition of either product/
metals or product/metals/AMP caused only a decrease in fluo-
rescence emission.
DISCUSSION
Low activity ratios (;0.3) are a property of wild-type FBPase
after limited proteolysis by papain or subtilisin (26). The max-
imum effect on the activity ratio due to proteolysis occurs when
one subunit per tetramer is cut. Thus, for the wild-type en-
zyme, an activity ratio of 1, as observed for the Lys50 3 Pro
mutant, requires an equal mixture of intact and once-proteo-
lyzed tetramers. Proteolysis of one of eight subunits then could
account for a diminished activity ratio in any FBPase. In SDS-
polyacrylamide gel electrophoresis of the Lys503 Pro mutant,
however, no fragments typical of proteolysis were evident. Fur-
thermore, loss of AMP inhibition due to proteolysis of wild-type
FBPase varied proportionately with the extent of subunit
cleavage. The 8000-fold increase in Ki for AMP far exceeds the
effect on AMP inhibition due to proteolysis, even in a com-
pletely proteolyzed system. Hence, the kinetic properties of the
Lys503 Pro mutant are not the consequence of proteolysis, but
rather the influence of a proline at position 50.
Allosteric inhibition of wild-type FBPase by TNP-AMP is
essentially identical to that caused by AMP, the only difference
being the absence of cooperativity in the kinetics and in the
binding of the fluorescent analog. In fact, TNP-AMP is indis-
tinguishable from formycin 59-monophosphate in its inhibition
and binding to wild-type FBPase. Formycin 59-monophosphate
also exhibits a Hill coefficient of unity (27), and crystal struc-
tures of complexes of formycin 59-monophosphate and AMP
with human FBPase are identical (28). The difference in Hill
coefficient may stem from subtle differences in conformation,
evident perhaps only in partially ligated states of FBPase.
Nonetheless, the fluorescence data clearly demonstrate tight
binding of TNP-AMP and the displacement of that analog from
FBPase by the addition of AMP. Hence, wild-type and Pro50
mutant FBPases are indistinguishable in their binding of TNP-
AMP and its displacement by AMP.
On the basis of kinetics, however, Pro50 mutant FBPase is
altogether insensitive to AMP. Inhibition of the Pro50 mutant
by AMP requires an 8000-fold increase in ligand concentration
and exhibits a different kinetic mechanism (noncompetitive
versus competitive with respect to Mg21). The apparent change
in kinetic mechanism may arise from the unmasking of a
secondary mechanism, due to the complete loss of allosteric
inhibition by AMP. That secondary mechanism may be the
direct coordination of AMP to the metal-ligated active site of
Pro50 mutant FBPase. Hence, if AMP binds tightly to the Pro50
mutant, as evidenced by the fluorescence data, but does not
inhibit, then proline at position 50 must interrupt the trans-
mission of the allosteric signal.
Kinetic data indicate the disruption of Loop 52–72 as the root
cause for the loss of allosteric properties in Pro50 mutant FB-
Pase. The Ka for Mg
21 is elevated 15-fold in the Pro50 mutant,
and K1 activation is lost. The kinetic mechanism of AMP
inhibition with respect to Mg21 is competitive in wild-type
FBPase. Hence, in wild-type FBPase, AMP elevates the appar-
ent dissociation constant of metals. A greatly elevated Ka for
Mg21, accompanied by the complete loss of AMP inhibition, is
consistent with an FBPase unable to achieve its high affinity
state for metal cations. On the basis of recent crystal structures
(10), the R-state engaged conformation of Loop 52–72 repre-
sents the high affinity state for metal cations and the catalyt-
ically productive state of FBPase. Pro50 mutant FBPase then
cannot achieve a engaged loop conformation.
Molecular modeling, CD spectroscopy, and fluorescence
emission from Trp57 strengthen the argument above. The mu-
tation of Lys50 to proline destabilizes the R-state engaged loop
and T-state disengaged loop conformations in slow cooling/
energy minimization protocols. The CD spectrum of Pro50 mu-
tant FBPase supports an altered state, conformationally unre-
sponsive to the binding of ligands. The indole group of Trp57 in
the Pro50/Trp57 double mutant does not enter its hydrophobic
pocket, as evidenced by the low fluorescence emission in the
presence of saturating products/metals. The several lines of
evidence provided here suggest that Loop 52–72 in Pro50 mu-
tant FBPase can achieve neither its T-state disengaged nor its
R-state engaged loop conformation. The complete loss of allo-
steric inhibition in Pro50 mutant FBPase suggests furthermore,
that Loop 52–72 is an essential element in the allosteric regu-
lation of FBPase.
The effects of the Ala513 Pro mutation are less dramatic, in
harmony with the results of modeling and CD spectroscopy.
The Pro51 mutant retains K1 activation and wild-type affinity
for divalent cations, but exhibits a significant increase in the Ki
for AMP. The mutation evidently destabilizes the T-state dis-
engaged conformation of Loop 52–72 relative to the R-state
engaged conformation, again consistent with the results of
modeling. In this respect, the Pro51 mutant and the Met71/72
double mutant (11) have similar effects on FBPase function. In
FIG. 6. Fluorescence spectra of the Trp57 and Trp57/Pro50 mu-
tants. In all cases, apoenzymes were in 50 mM Hepes (pH 7.5). Product
complexes had 5 mM Fru-6-P and 5 mM potassium Pi with either 5 or 35
mM Mg21 for the Trp57 and Trp57/Pro50 mutants, respectively. A, Trp57
mutant. Black line, apoenzyme; open circles, product complex; asterisks,
product complex 1 400 mM AMP. B, Pro50/Trp57 mutant. Black line,
apoenzyme; open circles, product complex; asterisks, product complex 1
20 mM AMP. A.U., arbitrary units.
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both instances, lessened AMP inhibition probably arises from a
perturbation in the equilibrium between engaged and disen-
gaged loop conformations in favor of the engaged state.
The Ki for Fru-2,6-P2 increases 20- and 30-fold in the Lys
50
3 Pro and Ala51 3 Pro mutants, respectively. The change in
binding affinity for Fru-2,6-P2 in these mutants must be indi-
rect and is most likely through a perturbation of conformation
states accessible to Loop 52–72. The increase in Ki for Fru-
2,6-P2 due to loop mutations does not come with an increase in
the Km for Fru-1,6-P2, as has been observed in other mutations
that increase the Ki for Fru-2,6-P2 (29). The observation above
is consistent with findings that suggest that Fru-2,6-P2 and
Fru-1,6-P2, although binding at the same site, evoke different
conformational responses from FBPase. For instance, at high
concentrations of Fru-2,6-P2, the Hill coefficient for AMP inhi-
bition changes from 2 to 1, and the saturation curve for Fru-
1,6-P2 changes from hyperbolic to sigmoidal (3, 30). At low
concentrations of Fru-2,6-P2, the Hill coefficient for Mg
21
changes from 2 to 1 (31). Finally, Fru-2,6-P2 protects FBPase
from loss of AMP inhibition and catalytic activity due to mod-
ification by acetylimidazole, whereas Fru-1,6-P2 protects only
against loss of activity (31). Although a complete understand-
ing of the above phenomena will come with further study,
mutations of the loop underscore a fundamental difference in
FBPase in its Fru-2,6-P2- and Fru-1,6-P2-ligated states.
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